Sensitivity and specificity of a visual depression screening instrument among HIV-positive individuals in Uganda, an Area with low literacy

AIDS and Behavior

Volumn 16, Issue 8, 2012, Pages 2399-2406

  Akena, Dickens ^a,b   Joska, John ^a   Musisi, Seggane ^b   Stein, Dan J ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b MAKERERE UNIVERSITY   (Uganda)

Author keywords

Depression; HIV AIDS; Low and middle income countries; Visual screening instrument

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EDUCATIONAL STATUS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSTRUMENTATION; MALE; MASS SCREENING; METHODOLOGY; PAIN ASSESSMENT; PERSONALITY TEST; PREVALENCE; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; PSYCHOMETRY; QUESTIONNAIRE; SENSITIVITY AND SPECIFICITY; UGANDA; VISION;

ADOLESCENT; ADULT; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EDUCATIONAL STATUS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MASS SCREENING; PAIN MEASUREMENT; PERSONALITY INVENTORY; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; QUESTIONNAIRES; SENSITIVITY AND SPECIFICITY; UGANDA; VISUAL PERCEPTION;

EID: 84868547969     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-012-0267-1     Document Type: Article

References (46)

1. Organization WH. HIV/AIDS and mental health: WHO;2008.
2. Ministry of Health of Uganda. Preliminary Results of the Uganda HIV/AIDS Sero-Behavioural Survey (UHSBS). Kampala: Ministry of Health; 2005.
3. Olatunji BO, Mimiaga MJ, O'Cleirigh C, Safren SA. Review of treatment studies of depression in HIV. International AIDS Society-USA Topics in HIV Medicine, Review-Depression and HIV. 2006;14(3):112-24.
4. Jeffrey A, Roberts JE. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry. 2001;158:725-30.
5. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997;349:1436-42.
6. Prince M, Patel V, Saxena S, et al. Global Mental Health 1 No health without mental health. Lancet. 2007;370:859-77.
7. Patel V, Simon G, Chowdhary N, Kaaya S, Araya R. Packages of care for depression in low-and middle-income countries. PLoS Med;2009:6(10):e1000159.
8. Patel V. Mental health in low-and middle-income countries. Br Med Bull. 2007;81-82:81-96.
9. Patel V, Weiss HA, Chowdhary N, et al. Effectiveness of an intervention led by lay health counsellors for depressive and anxiety disorders in primary care in Goa, India (MANAS): a cluster randomised controlled trial. Lancet. 2010;376: 2086-95.
10. Faydi E, Funk M, Kleintjes S, et al. An assessment of mental health policy in Ghana, South Africa, Uganda and Zambia. Health Res Policy Syst. 2011;9:17. Biomed central.
11. NICE. Depression: management of depression in primary and secondary care. National Institute of Clinical Excellence: London; 2004.
12. USPSTF. Screening for depression, recommendations and rationale: US preventive services Task Force 1996.
13. Gilbodyl S, Sheldon T, House A. Screening and case-finding instruments for depression: a meta-analysis. CMAJ. 2008;178(8): 997-1003.
14. Spitzer R, Kroenke K, Williams J. Validation and utility of a selfreport version of PRIME-MD: the PHQ Primary Care Study. J Am Med Assoc. 1999;282:1737-44.
15. Beck AI, Steer RA, Carbin MC. Psychometric properties of the beck depression inventory: twenty-five years of evaluation. Clin Psychol Rev. 1988;8:77-100.
16. Radloff LS. Center for epidemiologic studies depression scale (CESD). In: Center for Epidemiologic Studies NIMH, Publisher, West Publishing Company, ed. 1977.
17. Patel V, Pereira J, Coutinho L, Fernandes R, Fernandes J, Mann A. Poverty, psychological disorder and disability in primary care attenders in Goa, India. Br J Psychiatry. 1998;171:533-6.
18. World Health Organization. Mental Health Report, management of depression. www.who.int/mental-health/management/depression/definition/en/, 2011.
19. Puertas G, Patel V, Marshall T. Are visual measures of mood superior to questionnaire measures in non-Western settings? Soc Psychiatry Psychiatr Epidemiol. 2004;39:662-6.
20. Aitken RCB. Measurement of feelings using visual analogue scales. Proc R Soc Med. 1969;62:989-93.
21. Ickovics JR, Hamburger ME, Vlahov D. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA. 2001;285:1466-74.
22. Sherbourne CD, Hays RD, Fleishman JA, et al. Impact of psychiatric conditions on health-related quality of life in persons with HIV infection. Am J Psychiatry. 2000;157:248-54.
23. Ammassari A, Antinori A, Aloisi MS, et al. Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons. Psychosomatics. 2004;45:394-402.
24. Horberg MA, Silverberg MJ, Hurley LB, et al. Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. J Acquir Immune Defic Syndr. 2008;47:384-90.
25. Treisman G, Angelino A. Interrelation between psychiatric disorders and the prevention and treatment of HIV infection. Clin Infect Dis. 2007;45:S313-7.
26. Cruess DG, Douglas SD, Petitto JM, et al. Association of resolution of major depression with increased natural killer cell activity among HIV-seropositive women. Am J Psychiatry. 2005; 162:2125-30.
27. EvansDL, TenHave TR, Douglas SD, et al. Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection. Am J Psychiatry. 2002;159:1752-9.
28. Rabkin JG, Wagner GJ, Rabkin R. Fluoxetine treatment for depression in patients with HIV and AIDS: a randomized, placebo-controlled trial. Am J Psychiatry. 1999;156:101-7.
29. Bass J, Neugebauer R, Clougherty KF, et al. Group interpersonal psychotherapy for depression in rural Uganda: 6-month outcomes: randomised controlled trial. Br J Psychiatry. 2006;188:567-73.
30. Cuijpers P, van Straten A, van Schaik A, Andersson G. Psychological treatment of depression in primary care: a metaanalysis. Br J Gen Pract. 2009;59:e51-60.
31. Sheehan DV, Lecrubier Y, Harnett-Sheehan K. The Mini International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview. J Clin Psychiatry. 1998;59(suppl 20):22-33.
32. Okello ES, Ekblad S. Lay concepts of depression among the Baganda of Uganda: a pilot study. Transcult Psychiatry. 2006;43(2):287-313.
33. Nakasujja N, Skolasky RL, Musisi S, et al. Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda. BMC Psychiatry. 2010;10:44.
34. Spies G, Kader A, Kidd M, et al. Validity of the K-10 in detecting DSM-IV-defined depression and anxiety disorders among HIV-infected individuals. AIDS Care. 2009;21(9):1163-8.
35. Baggaley RF, Ganaba R, Filippi V, et al. Short communication: detecting depression after pregnancy the validity of the K10 and K6 in Burkina Faso. Trop Med Int Health. 2007;12(10):1225-9.
36. STATA Inventor; 4905 Lakeway Drive College Station. Texas 77845 USA 800-STATA-PC. assignee. STATA, Statistics/Data Analysis;2011.
37. Fischer JE, Bachmann LM, Jaeschke R. A readers' guide to the interpretation of diagnostic test properties. Clinical example of sepsis. Intensive Care Med. 2003;29(7):1043-51.
38. Swets JA. Measuring the accuracy of diagnostic systems. Science. 1998;240(4857):1285-93.
39. Mogga S, Prince M, Alem A, et al. Outcome of major depression in Ethiopia: population-based study. Br J Psychiatry. 2006; 189:241-6.
40. Monahan PO, Shacham E, Reece M, et al. Validity/reliability of PHQ-9 and PHQ-2 depression scales among adults living withHIV/AIDS in western Kenya. J Gen Intern Med. 2008;24(2):189-97.
41. Kertzman S, Aladjem Z, Milo R, et al. The utility of the Visual Analogue Scale for the assessment of depressive mood in cognitively impaired patients. Int J Geriatr Psychiatry. 2004;19:789-96.
42. Price CIM, Urless RH, Rodgers H. Can stroke patients use visual analogue scales? Stroke. 1999;30:1357-61.
43. Berg A, Lönnqvist J, Palomäki H, Kaste M. Assessment of depression after stroke: a comparison of different screening instruments. Stroke. 2009;40:523-9.
44. Myer L, Smit J, Roux LL, Parker S, Stein DJ, Seedat S. Common mental disorders among HIV-infected individuals in South Africa: prevalence, predictors, and validation of brief psychiatric rating scales. AIDS Patient Care STDs. 2008;22(2):147-58.
45. Omoro SAO, Fann JR, Weymuller EA, Macharia IM, Yueh B. Swahili translation and validation of the Patient Health Questionnaire-9 depression scale in the Kenyan head and neck cancer patient population. Int J Psychiatry Med. 2006;36(3):367-81. PMID 17236703.
46. Adewuya AO, Ola BA, Afolabi OO. Validity of the patient health questionnaire (PHQ-9) as a screening tool for depression amongst Nigerian university students. J Affect Disord. 2006;96(2006):89-93.